Expert Illustrations & Commentaries™: Iron Deficiency in Patients With Chronic Kidney Disease – An Inside Look at Pathogenesis and Evidence-Based Management

Release Date: October 6, 2021
Expiration Date: October 6, 2022

Activity Overview

This Expert Illustrations and Commentaries^TM is a video-based program in which two experts discuss the etiology, detection, and management of iron deficiency in patients with chronic kidney disease (CKD). In this activity the faculty focus on the mechanisms underlying CKD and the iron deficiency anemia (IDA), as well as best practices in the diagnosis and treatment of IDA. Their discussion is enriched with the use of video animations to illustrate CKD and IDA pathophysiology. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of IDA in patients with CKD and to improve outcomes for their patients with this disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from American Regent, Inc.

Target Audience

This educational activity is directed toward nephrologists. Internists, PCPs, NP/PA, hematologists, and nurses who are involved in the treatment of patients with iron deficiency and/or chronic kidney disease will also be invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Recognize the mechanisms that underlie the development of ID and IDA in patients with CKD.
• Identify the blood and iron indices used to diagnose ID and IDA in patients with CKD.
• Apply blood and iron indices to the routine evaluation of patients with CKD to detect ID and IDA.
• Evaluate optimal individualized therapy for patients with CKD and ID based on current evidence.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible entities.

Faculty

Jay B. Wish, MD
Professor of Clinical Medicine
Division of Nephrology
Indiana University School of Medicine
Chief Medical Officer of Outpatient Dialysis
Indiana University Health
Indianapolis, IN

Disclosures: Consultant: Vifor Pharma, Rockwell Medical, Akebia Therapeutics; Speaker’s Bureau: Akebia Therapeutics.

Daniel W. Coyne, MD
Professor of Medicine
Division of Nephrology
Medical Director of the Chromalloy American Kidney Center
Medical Director of the Medicine Multispecialty Clinics
Washington University
St. Louis, Missouri

Disclosures: Grant/Research Support: Bayer, GlaxoSmithKline, FibroGen, AstraZeneca; Consultants: GlaxoSmithKline, FibroGen, AstraZeneca, Otsuka Pharmaceutical, Ardelyx, Reata Pharmaceuticals, Fresenius Medical Care Renal Therapies Group; Speaker’s Bureau: Fresenius Medical Care Renal Therapies Group.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.